Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-08-018093
Filing Date
2008-03-17
Accepted
2008-03-17 17:17:19
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13D a08-8339_1sc13d.htm SC 13D 93127
2 EX-99.2 a08-8339_1ex99d2.htm EX-99.2 26077
3 EX-99.3 a08-8339_1ex99d3.htm EX-99.3 20354
  Complete submission text file 0001104659-08-018093.txt   141583
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Subject) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-37761 | Film No.: 08693988
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 707 STATE ROAD 206 PRINCETON NJ 08540
Business Address 707 STATE ROAD 206 PRINCETON NJ 08540 9087136001
MEDAREX INC (Filed by) CIK: 0000874255 (see all company filings)

EIN.: 222822175 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13D
SIC: 8731 Services-Commercial Physical & Biological Research